MiMedx Group Statistics
Total Valuation
MiMedx Group has a market cap or net worth of $1.00 billion. The enterprise value is $971.72 million.
| Market Cap | 1.00B |
| Enterprise Value | 971.72M |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, after market close.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MiMedx Group has 147.60 million shares outstanding. The number of shares has increased by 31.14% in one year.
| Shares Outstanding | 147.60M |
| Shares Change (YoY) | +31.14% |
| Shares Change (QoQ) | +2.79% |
| Owned by Insiders (%) | 2.32% |
| Owned by Institutions (%) | 65.28% |
| Float | 117.43M |
Valuation Ratios
The trailing PE ratio is 13.84 and the forward PE ratio is 20.99. MiMedx Group's PEG ratio is 2.97.
| PE Ratio | 13.84 |
| Forward PE | 20.99 |
| PS Ratio | 2.99 |
| Forward PS | 2.68 |
| PB Ratio | 6.43 |
| P/FCF Ratio | 29.17 |
| PEG Ratio | 2.97 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.14, with an EV/FCF ratio of 28.33.
| EV / Earnings | 13.10 |
| EV / Sales | 2.90 |
| EV / EBITDA | 19.14 |
| EV / EBIT | 21.02 |
| EV / FCF | 28.33 |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.12.
| Current Ratio | 3.29 |
| Quick Ratio | 2.50 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.38 |
| Debt / FCF | 0.57 |
| Interest Coverage | 7.01 |
Financial Efficiency
Return on equity (ROE) is 103.30% and return on invested capital (ROIC) is 57.19%.
| Return on Equity (ROE) | 103.30% |
| Return on Assets (ROA) | 35.90% |
| Return on Capital (ROIC) | 57.19% |
| Revenue Per Employee | $373,754 |
| Profits Per Employee | $82,855 |
| Employee Count | 895 |
| Asset Turnover | 1.62 |
| Inventory Turnover | 2.82 |
Taxes
| Income Tax | -34.51M |
| Effective Tax Rate | -87.05% |
Stock Price Statistics
The stock price has increased by +2.73% in the last 52 weeks. The beta is 1.91, so MiMedx Group's price volatility has been higher than the market average.
| Beta (5Y) | 1.91 |
| 52-Week Price Change | +2.73% |
| 50-Day Moving Average | 7.12 |
| 200-Day Moving Average | 7.46 |
| Relative Strength Index (RSI) | 43.46 |
| Average Volume (20 Days) | 828,047 |
Short Selling Information
The latest short interest is 5.61 million, so 3.80% of the outstanding shares have been sold short.
| Short Interest | 5.61M |
| Short Previous Month | 5.57M |
| Short % of Shares Out | 3.80% |
| Short % of Float | 4.78% |
| Short Ratio (days to cover) | 8.85 |
Income Statement
In the last 12 months, MiMedx Group had revenue of $334.51 million and earned $74.16 million in profits. Earnings per share was $0.49.
| Revenue | 334.51M |
| Gross Profit | 279.31M |
| Operating Income | 53.57M |
| Pretax Income | 39.65M |
| Net Income | 74.16M |
| EBITDA | 50.76M |
| EBIT | 46.24M |
| Earnings Per Share (EPS) | $0.49 |
Balance Sheet
The company has $48.49 million in cash and $19.45 million in debt, giving a net cash position of $29.03 million or $0.20 per share.
| Cash & Cash Equivalents | 48.49M |
| Total Debt | 19.45M |
| Net Cash | 29.03M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 155.73M |
| Book Value Per Share | 1.06 |
| Working Capital | 96.63M |
Cash Flow
In the last 12 months, operating cash flow was $36.80 million and capital expenditures -$2.50 million, giving a free cash flow of $34.30 million.
| Operating Cash Flow | 36.80M |
| Capital Expenditures | -2.50M |
| Free Cash Flow | 34.30M |
| FCF Per Share | $0.23 |
Margins
Gross margin is 83.50%, with operating and profit margins of 16.01% and 22.17%.
| Gross Margin | 83.50% |
| Operating Margin | 16.01% |
| Pretax Margin | 11.85% |
| Profit Margin | 22.17% |
| EBITDA Margin | 15.17% |
| EBIT Margin | 13.82% |
| FCF Margin | 10.25% |
Dividends & Yields
MiMedx Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.14% |
| Shareholder Yield | -31.14% |
| Earnings Yield | 7.41% |
| FCF Yield | 3.43% |
Analyst Forecast
The average price target for MiMedx Group is $12.00, which is 76.99% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 76.99% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 11.94% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 2, 2008. It was a reverse split with a ratio of 3235:10000.
| Last Split Date | Apr 2, 2008 |
| Split Type | Reverse |
| Split Ratio | 3235:10000 |
Scores
MiMedx Group has an Altman Z-Score of 11.04 and a Piotroski F-Score of 6.
| Altman Z-Score | 11.04 |
| Piotroski F-Score | 6 |